Targets and strategies for vaccine development against SARS-CoV-2
The SARS-CoV-2, previously called a novel coronavirus, that broke out in the Wuhan city of China caused a significant number of morbidity and mortality in the world. It is spreading at peak levels since the first case reported and the need for vaccines is in immense demand globally. Numerous treatme...
- Autores:
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2021
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/17030
- Acceso en línea:
- https://www.sciencedirect.com/science/article/pii/S0753332221000391?dgcid=raven_sd_search_email
http://hdl.handle.net/20.500.12010/17030
https://doi.org/10.1016/j.biopha.2021.111254
- Palabra clave:
- SARS-CoV-2
COVID-19
Clinical trials
SARS-CoV-2
Vaccine
Pandemic Antigen
- Rights
- License
- Abierto (Texto Completo)